Christopher Campbell > DLA Piper LLP (US) > Atlanta, United States > Lawyer Profile

DLA Piper LLP (US)’s product liability team is a trusted defender of global pharma and medical device companies, having successfully handled numerous high-stakes disputes. It has defended or ended several mass torts through resolution, dispositive preemption, Daubert hearings, and other motions. Leveraging its cross-practice expertise, the team collaborates closely with appellate, regulatory, and life science partners. Atlanta-based Christopher Campbell, co-chair of the product liability group, leads high-profile matters such as Bayer’s global Essure litigation and its phenylephrine cough-cold MDL litigation. Ilana Hope Eisenstein, chair of US litigation based in Philadelphia, specializes in complex issues, developing and managing legal strategy. In New York, Loren Brown chairs the wider US disputes practice and leads the firm’s representation of Novo Nordisk as national trial counsel in litigation related to diabetes and obesity medications Ozempic, Wegovy, and Rybelsu. Boston-based Matthew Holian is another key figure in the practice, frequently serving as national counsel in complex, multi-jurisdictional matters. ‘Client-focused’ Katie Insogna, also in Boston, is ‘outstanding at managing the intricacies of a day-to-day high-stakes mass tort’, while New York’s Lucas Przymusinski leverages his medical background to drive legal strategy. Meanwhile, Steve Huffaker, who joined the Austin office from King & Spalding LLP in September 2024, focuses on mass tort coordination and strategy, early case resolution, group settlements, litigation risk strategy, and fact and expert witness development and discovery.

Operating from offices in Los Angeles, New York, Washington DC, and San Francisco, the consumer product liability and mass torts team at DLA Piper LLP (US) is known for defending high-profile clients in mass torts, class actions, and complex consumer litigation. Attorneys of the firm are praised by clients for their ‘high level of expertise & experience, and an absolute commitment to the assignment’, often handling precedent-setting cases for global companies such as Apple, Johnson & Johnson, Danone, and MGM across various sectors, including pharma, healthcare, media and entertainment, and food & drink manufacturing. The group’s expertise further extends to environmental matters such as PFAS litigation, microplastics claims, and sustainability issues, securing key motions to dismiss for clients like Danone and Starz Entertainment. Prominent attorneys in the group include Atlanta based Christopher Campbell, and LA based Angela Agrusa , co-chairs of the firm’s product liability & mass torts group, with Agrusa having notably defended over 50 putative class actions with potential exposure exceeding $100bn. Keara Gordon, a seasoned trial lawyer, has won precedent-setting motions to dismiss for clients including NYU and KLM Airlines, while Colleen Gulliver focuses on emerging issues like sustainability and environmental contamination, representing international pharmaceutical companies such as Pfizer. Both Gulliver and Gordon are based in New York. San Francisco based Isabelle Ord, co-chair of the global class action litigation practice, is recognized for her work in business disputes, fraud, and regulatory enforcement matters.